Early clinical trials have been completed on a second Russian vaccine, a health official said Wednesday, moving it closer to registration under the Russian approach of approving vaccines for emergency use before beginning late-stage trials to determine whether they are effective.
Early trials provide information about safety, though rare side effects may go undetected until much larger late-stage trials are conducted. The later trials, known as Phase 3, are the only means of determining whether a vaccine actually protects against the coronavirus.
Russia registered its first Covid-19 vaccine — one based on common cold viruses — in August, and is now offering a small number of doses outside of trials to people at elevated risk of infection, like health care workers. Western vaccine experts criticized the Russian approach as potentially dangerous.
Anna Papova, the head of Rospotrebnadzor, a Russian agency regulating health care, said on Wednesday that researchers had completed early clinical trials of a different vaccine, based on proteins that mimic those in the coronavirus.
Ms. Papova defended the Russian regulatory approach, saying that it drew on a long history of Soviet vaccine development. “The Russian vaccines deserve absolutely no criticism,” she said.
Her agency said earlier this month that it planned to register the second vaccine, made by Vektor, a Siberian laboratory that studied biological weapons during the Cold War, by Oct. 15. A third Russian vaccine, made by the Chumakov Institute in Moscow and based on inactivated coronavirus, is now in early-stage trials.
I run this site in my spare time and thoroughly enjoy giving you all positive news! If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.
ENJOY FEEL GOOD, INSPIRING STORIES AND VIDEOS ?
Our new page here is just what you need, with just good news, feel good stories unrelated to COVID.